TrialSignal transduction and targeted therapy2020

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357.

Liang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.